Tectonic Therapeutic
TECX
66 hedge funds and large institutions have $268M invested in Tectonic Therapeutic in 2019 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 25 increasing their positions, 17 reducing their positions, and 3 closing their positions.
400% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 3
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
47% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 17
16% more funds holding
Funds holding: 57 → 66 (+9)
0.23% less ownership
Funds ownership: 5.95% → 5.71% (-0.23%)
29% less capital invested
Capital invested by funds: $379M → $268M (-$111M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$4.48M |
| 2 |
JP Morgan Chase
New York
|
+$4.02M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$3.66M |
| 4 |
BlackRock
New York
|
+$3.13M |
| 5 |
AP
AlpInvest Partners
Amsterdam,
Netherlands
|
+$2.72M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Blackstone Inc
New York
|
-$26.6M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$8.08M |
| 3 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$3.72M |
| 4 |
O
OrbiMed
New York
|
-$1.66M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$449K |
TECX Hedge Fund Activity: Q2 2019 in Review
66 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Tectonic Therapeutic (TECX) for Q2 2019, worth a combined $268M — down 29% from $379M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new TECX positions and 3 closed out — a net gain of 12 holders — while 25 added to existing stakes and 17 trimmed.
The largest buyer was PFM Health Sciences, opening a new position worth an estimated $4.48M. The largest seller was Blackstone Inc, cutting an estimated $26.6M.
- 66 institutional investors held Tectonic Therapeutic (TECX) as of Q2 2019, up from 57 in Q1 2019.
- Funds reported $268M of Tectonic Therapeutic stock for Q2 2019, down 29% quarter-over-quarter.
- 15 funds opened new Tectonic Therapeutic positions in Q2 2019 and 3 closed out, a net change of +12 holders.
- The largest Tectonic Therapeutic buyer in Q2 2019 was PFM Health Sciences, an estimated $4.48M added.
- The largest Tectonic Therapeutic seller in Q2 2019 was Blackstone Inc, an estimated $26.6M sold.
Based on aggregated 13F filings for Q2 2019.